Patent details

EP3035965 Title: BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF

Basic Information

Publication number:
EP3035965
PCT Application Number:
US2014051790
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148378581
PCT Publication Number:
WO2015026892
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF
French Title of Invention:
DIABODIES MONOVALENTS BI-SPÉCIFIQUES QUI SONT CAPABLES DE SE LIER À CD 123 ET CD 3, ET LEURS UTILISATIONS
German Title of Invention:
BISPEZIFISCHE MONOVALENTE DIABODIES MIT FÄHIGKEIT ZUR BINDUNG VON CD123 UND CD3 UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
20/08/2014
Grant date:
11/11/2020
EP Publication Date:
29/06/2016
PCT Publication Date:
26/02/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/11/2020
EP B1 Publication Date:
11/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/08/2022
Expiration date:
20/08/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/11/2020
 
 

Name:
MacroGenics, Inc.
Address:
9704 Medical Center Drive, Rockville, MD 20850, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
18/03/2021
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
BONVINI, Ezio
Address:
United States (US)

2

Name:
JOHNSON, Leslie S.
Address:
United States (US)

3

Name:
MOORE, Paul A.
Address:
United States (US)

4

Name:
CHICHILI, Gurunadh Reddy
Address:
United States (US)

5

Name:
HUANG, Ling
Address:
United States (US)

6

Name:
ALDERSON, Ralph Froman
Address:
United States (US)

Priority

1

Priority Number:
201361869510 P
Priority Date:
23/08/2013
Priority Country:
United States (US)

2

Priority Number:
201361907749 P
Priority Date:
22/11/2013
Priority Country:
United States (US)

3

Priority Number:
13198784
Priority Date:
20/12/2013
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Number:
201461990475 P
Priority Date:
08/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61P 11/06; A61P 17/02; A61P 19/02; A61P 29/00; A61P 35/00; A61P 35/02; A61P 35/04; A61P 37/00; A61P 37/08; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202046
Publication date:
11/11/2020
Description:
Grant (B1)

2

Issue number:
202051
Publication date:
16/12/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/08/2021
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
18/03/2021 Power Of Attorney 2
23/03/2021 Outgoing Correspondence 1